GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) » Definitions » Shiller PE Ratio

Shanghai Fosun Pharmaceutical (Group) Co (SHSE:600196) Shiller PE Ratio : 18.02 (As of May. 17, 2024)


View and export this data going back to 1998. Start your Free Trial

What is Shanghai Fosun Pharmaceutical (Group) Co Shiller PE Ratio?

As of today (2024-05-17), Shanghai Fosun Pharmaceutical (Group) Co's current share price is ¥23.78. Shanghai Fosun Pharmaceutical (Group) Co's E10 for the quarter that ended in Mar. 2024 was ¥1.32. Shanghai Fosun Pharmaceutical (Group) Co's Shiller PE Ratio for today is 18.02.

The historical rank and industry rank for Shanghai Fosun Pharmaceutical (Group) Co's Shiller PE Ratio or its related term are showing as below:

SHSE:600196' s Shiller PE Ratio Range Over the Past 10 Years
Min: 16.3   Med: 30.76   Max: 68.81
Current: 18.02

During the past years, Shanghai Fosun Pharmaceutical (Group) Co's highest Shiller PE Ratio was 68.81. The lowest was 16.30. And the median was 30.76.

SHSE:600196's Shiller PE Ratio is ranked better than
68.48% of 533 companies
in the Drug Manufacturers industry
Industry Median: 25.16 vs SHSE:600196: 18.02

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Shanghai Fosun Pharmaceutical (Group) Co's adjusted earnings per share data for the three months ended in Mar. 2024 was ¥0.230. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ¥1.32 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Shanghai Fosun Pharmaceutical (Group) Co Shiller PE Ratio Historical Data

The historical data trend for Shanghai Fosun Pharmaceutical (Group) Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Fosun Pharmaceutical (Group) Co Shiller PE Ratio Chart

Shanghai Fosun Pharmaceutical (Group) Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.06 47.03 38.38 26.21 18.96

Shanghai Fosun Pharmaceutical (Group) Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.77 22.91 21.05 18.96 17.46

Competitive Comparison of Shanghai Fosun Pharmaceutical (Group) Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Fosun Pharmaceutical (Group) Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Fosun Pharmaceutical (Group) Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Fosun Pharmaceutical (Group) Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Shanghai Fosun Pharmaceutical (Group) Co's Shiller PE Ratio falls into.



Shanghai Fosun Pharmaceutical (Group) Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Shanghai Fosun Pharmaceutical (Group) Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=23.78/1.32
=18.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Fosun Pharmaceutical (Group) Co's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Shanghai Fosun Pharmaceutical (Group) Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.23/115.2271*115.2271
=0.230

Current CPI (Mar. 2024) = 115.2271.

Shanghai Fosun Pharmaceutical (Group) Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.260 98.200 0.305
201409 0.240 98.900 0.280
201412 0.230 99.000 0.268
201503 0.230 99.900 0.265
201506 0.330 99.500 0.382
201509 0.250 100.500 0.287
201512 0.240 100.600 0.275
201603 0.270 102.200 0.304
201606 0.380 101.400 0.432
201609 0.290 102.400 0.326
201612 0.260 102.600 0.292
201703 0.310 103.200 0.346
201706 0.380 103.100 0.425
201709 0.290 104.100 0.321
201712 0.280 104.500 0.309
201803 0.280 105.300 0.306
201806 0.350 104.900 0.384
201809 0.200 106.600 0.216
201812 0.240 106.500 0.260
201903 0.280 107.700 0.300
201906 0.310 107.700 0.332
201909 0.220 109.800 0.231
201912 0.490 111.200 0.508
202003 0.230 112.300 0.236
202006 0.440 110.400 0.459
202009 0.300 111.700 0.309
202012 0.460 111.500 0.475
202103 0.330 112.662 0.338
202106 0.640 111.769 0.660
202109 0.420 112.215 0.431
202112 0.460 113.108 0.469
202203 0.180 114.335 0.181
202206 0.420 114.558 0.422
202209 0.340 115.339 0.340
202212 0.490 115.116 0.490
202303 0.370 115.116 0.370
202306 0.300 114.558 0.302
202309 0.180 115.339 0.180
202312 0.030 114.781 0.030
202403 0.230 115.227 0.230

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Shanghai Fosun Pharmaceutical (Group) Co  (SHSE:600196) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Shanghai Fosun Pharmaceutical (Group) Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Shanghai Fosun Pharmaceutical (Group) Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Fosun Pharmaceutical (Group) Co (SHSE:600196) Business Description

Traded in Other Exchanges
Address
No. 1289 Yishan Road, Building A, Fosun Technology Park, Shanghai, CHN, 200233
Shanghai Fosun Pharmaceutical (Group) Co Ltd is a specialty and generic drug manufacturing company. Shanghai Fosun maintains five business segments, including Pharmaceutical manufacturing, Healthcare Services, Medical devices, and medical diagnosis. Most of the company's revenue is generated by its Pharmaceutical manufacturing segment. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Shanghai Fosun Pharmaceutical (Group) Co (SHSE:600196) Headlines

No Headlines